Vivo Bio Tech Limited (VIVOBIOT.BO)
INR 35.68
(2.76%)
INR 35.68
(2.76%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 454.51 Million INR | -12.98% |
| 2022 | 522.3 Million INR | 1.63% |
| 2021 | 513.91 Million INR | -0.74% |
| 2020 | 517.75 Million INR | -6.46% |
| 2019 | 553.52 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 101.34 Million INR | -13.81% |
| 2023 Q1 | 115.82 Million INR | -21.52% |
| 2023 Q4 | 117.58 Million INR | -8.49% |
| 2023 Q3 | 128.48 Million INR | 38.73% |
| 2023 FY | 454.51 Million INR | -12.98% |
| 2023 Q2 | 92.61 Million INR | -20.03% |
| 2022 FY | 522.3 Million INR | 1.63% |
| 2022 Q4 | 147.58 Million INR | 9.03% |
| 2022 Q3 | 135.36 Million INR | 6.81% |
| 2022 Q1 | 112.63 Million INR | -26.41% |
| 2022 Q2 | 126.72 Million INR | 12.51% |
| 2021 Q2 | 101.68 Million INR | -21.76% |
| 2021 Q1 | 129.97 Million INR | -19.18% |
| 2021 Q3 | 129.2 Million INR | 27.06% |
| 2021 Q4 | 153.05 Million INR | 18.46% |
| 2021 FY | 513.91 Million INR | -0.74% |
| 2020 Q3 | 118.74 Million INR | -19.03% |
| 2020 Q2 | 146.65 Million INR | 60.21% |
| 2020 Q1 | 91.54 Million INR | -36.23% |
| 2020 FY | 517.75 Million INR | -6.46% |
| 2020 Q4 | 160.81 Million INR | 35.43% |
| 2019 Q4 | 143.55 Million INR | 1.76% |
| 2019 FY | 553.52 Million INR | 0.0% |
| 2019 Q3 | 141.07 Million INR | 4.15% |
| 2019 Q1 | 133.45 Million INR | -3.05% |
| 2019 Q2 | 135.44 Million INR | 1.49% |
| 2018 Q4 | 137.65 Million INR | -4.55% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 140.64 Million INR | 0.0% |
| 2018 Q3 | 144.21 Million INR | 2.53% |
| 2017 Q1 | 109.63 Million INR | 27.69% |
| 2017 Q4 | 123.35 Million INR | 2.2% |
| 2017 Q3 | 120.69 Million INR | 3.71% |
| 2017 Q2 | 116.38 Million INR | 6.16% |
| 2016 Q1 | 81.81 Million INR | 11.3% |
| 2016 Q4 | 85.85 Million INR | 1.28% |
| 2016 Q3 | 84.77 Million INR | -4.94% |
| 2016 Q2 | 89.18 Million INR | 9.0% |
| 2015 Q3 | 79.14 Million INR | 8.92% |
| 2015 Q4 | 73.5 Million INR | -7.12% |
| 2015 Q1 | 60.52 Million INR | 1.14% |
| 2015 Q2 | 72.66 Million INR | 20.06% |
| 2014 Q4 | 59.83 Million INR | 28.85% |
| 2014 Q1 | 36.66 Million INR | -9.67% |
| 2014 Q2 | 11.08 Million INR | -69.77% |
| 2014 Q3 | 46.44 Million INR | 318.94% |
| 2013 Q4 | 40.59 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 2.22 Billion INR | 79.573% |
| Checkpoint Trends Limited | 11.3 Million INR | -3918.905% |
| Everest Organics Limited | 1.97 Billion INR | 76.957% |
| GUJARAT INJECT (KERALA) LTD. | 57.88 Million INR | -685.219% |
| NATURO INDIABULL LIMITED | 418.93 Million INR | -8.493% |
| NEXUS SURGICAL AND MEDICARE LI | 34.74 Million INR | -1208.237% |
| Rajnish Wellness Limited | 766.84 Million INR | 40.73% |
| Rama Vision Limited | 895.7 Million INR | 49.257% |